Nuo Therapeutics Statistics
Total Valuation
AURX has a market cap or net worth of 72.44 million. The enterprise value is 71.99 million.
| Market Cap | 72.44M |
| Enterprise Value | 71.99M |
Important Dates
The next estimated earnings date is Thursday, April 16, 2026.
| Earnings Date | Apr 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AURX has 48.29 million shares outstanding. The number of shares has increased by 4.16% in one year.
| Current Share Class | 48.29M |
| Shares Outstanding | 48.29M |
| Shares Change (YoY) | +4.16% |
| Shares Change (QoQ) | +1.10% |
| Owned by Insiders (%) | 48.07% |
| Owned by Institutions (%) | 2.13% |
| Float | 20.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 21.86 |
| PB Ratio | -75.73 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -28.66 |
| EV / Sales | 21.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -63.16 |
Financial Position
The company has a current ratio of 1.06
| Current Ratio | 1.06 |
| Quick Ratio | 0.85 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.09 |
| Interest Coverage | -3,130.16 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -103.65% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -466.58% |
| Weighted Average Cost of Capital (WACC) | -4,428.57% |
| Revenue Per Employee | 331,351 |
| Profits Per Employee | -251,222 |
| Employee Count | 10 |
| Asset Turnover | 2.18 |
| Inventory Turnover | 6.02 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.25% in the last 52 weeks. The beta is -807.05, so AURX's price volatility has been lower than the market average.
| Beta (5Y) | -807.05 |
| 52-Week Price Change | -6.25% |
| 50-Day Moving Average | 1.58 |
| 200-Day Moving Average | 1.76 |
| Relative Strength Index (RSI) | 50.04 |
| Average Volume (20 Days) | 6,062 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, AURX had revenue of 3.31 million and -2.51 million in losses. Loss per share was -0.05.
| Revenue | 3.31M |
| Gross Profit | 2.22M |
| Operating Income | -2.52M |
| Pretax Income | -2.51M |
| Net Income | -2.51M |
| EBITDA | -2.43M |
| EBIT | -2.52M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 548,946 in cash and 97,346 in debt, with a net cash position of 451,600 or 0.01 per share.
| Cash & Cash Equivalents | 548,946 |
| Total Debt | 97,346 |
| Net Cash | 451,600 |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | -956,559 |
| Book Value Per Share | -0.02 |
| Working Capital | 73,598 |
Cash Flow
In the last 12 months, operating cash flow was -864,971 and capital expenditures -274,756, giving a free cash flow of -1.14 million.
| Operating Cash Flow | -864,971 |
| Capital Expenditures | -274,756 |
| Depreciation & Amortization | 85,463 |
| Net Borrowing | 500,000 |
| Free Cash Flow | -1.14M |
| FCF Per Share | -0.02 |
Margins
Gross margin is 66.94%, with operating and profit margins of -75.95% and -75.82%.
| Gross Margin | 66.94% |
| Operating Margin | -75.95% |
| Pretax Margin | -75.82% |
| Profit Margin | -75.82% |
| EBITDA Margin | -73.37% |
| EBIT Margin | -75.95% |
| FCF Margin | n/a |
Dividends & Yields
AURX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.16% |
| Shareholder Yield | -4.16% |
| Earnings Yield | -3.47% |
| FCF Yield | -1.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AURX has an Altman Z-Score of -11.34 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.34 |
| Piotroski F-Score | 2 |